•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
AI-powered remote health care startup Medvi is targeting $1.8 billion in revenue by the end of 2026, according to reporting cited by The New York Times. The company, founded in Los Angeles by Matthew Gallagher (41) and his co-founder brother, is described as operating almost entirely through AI, despite not being positioned as a technology company.
Medvi’s website and marketing materials are built using AI tools, including AI-assisted programming for its digital platform and AI-generated images for advertising. The company’s outreach and customer service are also highly automated. The founder has used “vibe coding” with tools such as ChatGPT, Claude, and Grok to build the platform, while marketing content is created using tools including Midjourney and Runway. ElevenLabs is cited as supporting customer communication, with these components linked into a largely automated operating system.
Medvi was established in September 2024 with initial capital of $20,000. By 2025, it generated about $401 million in revenue while serving 250,000 customers. For 2026, the company is forecast to reach $1.8 billion in revenue.
The article links Medvi’s growth to the economics of U.S. telehealth, which has often been described as operating near a precarious legal boundary. Instead of in-person clinic visits, users communicate by phone or online platforms, and prescriptions are arranged and delivered at lower cost than traditional channels.
Medvi is described as operating in a similar way to other telehealth firms that pursue high-demand, high-margin categories. In particular, it is said to supply GLP-1 therapies. GLP-1 drugs are typically prescribed for type 2 diabetes and weight loss, and their use requires prescription and physician oversight. The weight-loss effects have contributed to strong demand.
In the United States, the drugs are described as costing around $1,000 per month, while Medvi is said to offer them for about $300. The price gap is described as attracting hundreds of thousands of people who bypass traditional medical care, contributing to Medvi’s rapid growth.
Critics have raised concerns about Medvi’s marketing and compliance. Sheel Mohnot, a Silicon Valley venture capitalist, said on X that Medvi’s advertising shows signs of misrepresentation, alleging that the company runs more than 800 ads using “fake doctor images,” along with thousands of other testimonials and organizations that do not exist.
The article also notes that Medvi has reportedly received a warning from U.S. regulators in February, highlighting regulatory risks tied to the company’s expansion.
While Medvi’s growth has drawn attention in the tech community, the reporting emphasizes two central issues: the sustainability of an AI-driven operating model in a regulated health-care environment, and the legal and regulatory risks associated with its telehealth approach.
Premium gym chains are entering a “golden era” that is ending or already in decline, as rising operating costs collide with shifting consumer preferences toward more flexible, community-based ways to exercise. Long-term memberships are shrinking, margins are pressured by higher rents and facility expenses, and competition from smaller, more personalized…
